Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
32.47
-0.55 (-1.67%)
May 22, 2026, 4:00 PM EDT - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $1.93 billion as of May 22, 2026. Its market cap has increased by 298.38% in one year.
Market Cap
1.93B
Enterprise Value
1.55B
1-Year Change
298.38%
Ranking
Category
Stock Price
$32.47
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $1.93B, an increase of 194.97%. That is a compound annual growth rate of 25.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 1.96B | 39.95% |
| Dec 31, 2025 | 1.40B | 91.90% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 2.03B |
| Pharvaris | 2.01B |
| Aurinia Pharmaceuticals | 1.98B |
| Mesoblast | 1.96B |
| Ascentage Pharma Group International | 1.96B |
| ADMA Biologics | 1.95B |
| Viridian Therapeutics | 1.94B |
| Generate Biomedicines | 1.92B |